18F-AV-1451 PET Imaging in Subjects With Subacute Traumatic Brain Injury

Trial Profile

18F-AV-1451 PET Imaging in Subjects With Subacute Traumatic Brain Injury

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 12 Feb 2016

At a glance

  • Drugs Flortaucipir F 18 (Primary)
  • Indications Brain injuries
  • Focus Diagnostic use
  • Sponsors Avid Radiopharmaceuticals
  • Most Recent Events

    • 04 Feb 2016 Status changed from not yet recruiting to withdrawn prior to enrolment, according to ClinicalTrials.gov record.
    • 05 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top